Advanced Search

 

Study ID Status Title Patient Level Data
105-044 Completed An Evaluation of Lamotrigine Monotherapy for the Treatment of Newly–Diagnosed Typical Absence Seizures in Children and Adolescents
105049 Completed A randomised, placebo-controlled, 4-period, incomplete block, crossover study of 7 days dosing of intranasal GW784568X (100 mg, 200 mg and 400 mg once daily), fluticasone propionate (200 mg once daily) and placebo (blinded for GW784568X vs placebo) to evaluate the efficacy and safety Study Listed on ClinicalStudyDataRequest.com
105-052 Completed Single-dose pharmacokinetics of lamotrigine in pediatric patients with epilepsy in the absence of other antiepileptic drugs.
105095 Completed An open-label, randomized (with respect to different doses of casopitant), two-period parallel group study to evaluate the potential pharmacokinetic interaction of co-administered casopitant and digoxin in healthy subjects Study Listed on ClinicalStudyDataRequest.com
105106 Completed A parallel-group, double-blind, randomized, placebo-controlled, active comparator, multicenter study to evaluate the efficacy, safety, tolerability and pharmacokinetics of two doses of GSK232802 administered orally as monotherapy for 12 weeks in healthy postmenopausal women with moderate to extremely severe vasomotor symptoms
105120 Completed An Open-label Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Rosuvastatin when Co-administered with Eltrombopag (SB-497115-GR) in Healthy Adult Subjects
105122 Completed Phase I Bioequivalence Study for SB-497115-GR Phase II and Phase III Tablets
105-122 Completed Report of a study to investigate the pharmacokinetic and pharmacodynamic interaction of lamotrigine (300 mg) and lorazepam (1 mg) in healthy volunteers.
105-123 Completed Lamotrigine as add-on therapy in patients with a clinical diagnosis of a Lennox-Gastaut syndrome (severe generalised epilepsy of childhood onset). A multicentre, double-blind, placebo-controlled, parallel group study. Study Listed on ClinicalStudyDataRequest.com
105-124-C93 Completed A Multicentre Double-Blind Randomised Comparative Trial of Lamotrigine and Carbamazepine in Elderly Patients with Newly Diagnosed Epilepsy
105-136 Completed Open Randomised Comparison of Lamotrigine with Carbamazepine as Monotherapy in Patients with Partial SeizuresExtensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
105194 Completed An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety and/or efficacy of AVODART(dutasteride) administered in Korean BPH(Benign Prostatic Hyperplasia) patients according to the prescribing information
105209 Completed A randomized double-blind placebo-controlled crossover dose escalation study to examine the safety tolerability pharmacodynamics and pharmacokinetics of inhaled doses of GSK233719 in healthy normal volunteers (single and repeat dosing) and in healthy CYP2D6 poor metaboliser volunteers (single or repeat dosing). Study Listed on ClinicalStudyDataRequest.com
105211 Completed A randomised, double-blind, placebo-controlled, dose ascending, 2-cohort, parallel group study to examine the safety, tolerability and pharmacokinetics of once-daily inhaled doses of GSK573719 formulated with the excipient Magnesium Stearatein COPD subjects for 7 days Study Listed on ClinicalStudyDataRequest.com
105229 Completed A double-blinded, randomized, placebo-controlled, staggered-parallel, escalating dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous injections of GSK 716155 in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com
105239 (mth24-30) Completed Booster Vaccination Study to Assess Immunogenicity & Safety of a Dose of GSK Biologicals' Mencevax™ ACWY & 1/5th of a Dose of Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study Study Listed on ClinicalStudyDataRequest.com
105-30 Completed A Multicenter, Double-Blind, Active-Control Evaluation of The Efficacy and Safety of Lamotrigine Monotherapy in Patients With Partial Seizures
105331 Completed A single-centre, randomised, double-blind placebo-controlled, dose-ascending, parallel-group study to evaluate the safety, tolerability, extra-pulmonary pharmacodynamics and systemic and urinary pharmacokinetics of GSK233705 administered twice daily for 14 days in healthy male subjects Study Listed on ClinicalStudyDataRequest.com
105377 Completed A randomised, open-label, parallel-group design study to evaluate the pharmacokinetic characteristics, safety and tolerability of single oral doses of three prototype 300mg enteric coated - modified release formulations of Lamotrigine in healthy subjects. Study Listed on ClinicalStudyDataRequest.com
105414 Completed A study to investigate the effects of orally administered single dose prednisolone on carbohydrate metabolism using oral glucose tolerance testing.
105467 Completed A placebo-controlled, single-blind, randomised, parallel group, 28-day repeat dose study to investigate the tolerability, safety and steady state pharmacokinetics of GSK372475 in healthy young and elderly, male and female subjects
105-503 Completed Pharmacokinetics and tolerability of a single oral dose of lamotrigine in liver disease.
105517/003 Completed Effect of carvedilol, administered orally at doses of 12.5, 25.0 and 50.0mg, on renal function in healthy subjects.
105517/008 Completed A pharmacokinetic study of carvedilol, 25 mg orally (SK&F 105517) to study the intra-subject variability and stereoselectivity of the pharmacokinetics in healthy subjects.
105517/010 Completed A dose proportionality study of carvedilol enantiomers following doses of racemic carvedilol (SK&F 105517 – capsules) of 6.25, 12.5, 25.0 and 37.5mg orally in healthy subjects.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.